Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trial.
Nat Commun · 2025-Jul-21 · PMID 40691143
Progression Free Survival
Fig. 3. Pro-inflammatory pathway transcriptionally upregulated in R- vs NR-mesotheliomas. A Box plots showing relative chemokine expression corresponding to CCL5, CCL16, CCL17, CCL19, CCL21 and CCL23 transcripts in R- vs NR-mesotheliomas (* indicates a Wilcoxon signed rank test, two-sided p -value equal to or less than 0.05, ** equal to or less than 0.01). Y -axis units correspond to fragments per kilobase of feature per million mapped reads (TPM) normalised counts. The boxplots show the median line and interquartile range (IQR, 25 th −75 th percentiles), with the whiskers extending to the maximum and minimum values. B Boxplots showing Interleukins IL17C, IL23A and IL24 transcripts in R- vs NR-mesotheliomas. The boxplots show the median line and interquartile range (IQR, 25 th −75 th percentiles), with the whiskers extending to the maximum and minimum values. C Scatter plot showing CCL19 versus B lymphocyte lineage as determined by transcriptome deconvolution. Blue dots correspond to R-mesotheliomas and purple to NR (spearman’s rank correlation coefficient= 0.85, p = 1.1 × 10 −7 ). D Scatter plot showing IL24 versus B lymphocyte lineage as determined by transcriptome deconvolution. Blue dots correspond to R-mesotheliomas and purple to NR (spearman’s rank correlation coefficient= 0.66, two-sided p = 0.0006). E Box plot comparing IL24/EMT ratio in R- vs NR- mesotheliomas (*** indicates a significance p < 0.0001). F Receiver operating characteristics plot for the ratio of IL24 transcript levels to EMT enrichment score in R- vs NR-mesotheliomas. AUROC was 0.9. G Left. Box plot showing the relative enrichment of CD8 immune cells in R (blue) vs NR (purple) mesotheliomas deconvoluted using MCP-Counter, Wilcoxon two-sided p = 0.024). This boxplot shows the median line and interquartile range (IQR, 25 th −75 th percentiles), with the whiskers extending to the maximum and minimum values. Right. Scatter plots showing CD8 + T cell enumeration by deconvolution versus multiplex immunofluorescence (mIF) respectively. Spearman’s r = 0.6018, p = 0.002. H Correlation matrix showing a positive (blue) correlation between immune deconvolution algorithms (CIBERSORT, MCP Counter) and multiplex immunofluorescence for CD8 T cell enumeration. I Kaplan Meier curves showing progression free survival of CD8 T cells, EMT, or IL24/CCL19 ratio (dichotomised by the medians) in an independent (MEDUSA) cohort.
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
| Curve | 序号 | X (norm) | Y (norm) | X (real) | Y (real) | X (pixel) | Y (pixel) |
|---|---|---|---|---|---|---|---|
| 1 | 1 | 0.0000 | 0.4267 | -900.0000 | 55 | 68 | |
| 1 | 2 | 0.0766 | 0.4267 | 313.3333 | 76 | 68 | |
| 1 | 3 | 0.0803 | 0.4267 | 406.6667 | 77 | 68 | |
| 1 | 4 | 0.0839 | 0.4267 | 500.0000 | 78 | 68 | |
| 1 | 5 | 0.0876 | 0.4133 | 593.3333 | 79 | 69 | |
| 1 | 6 | 0.0912 | 0.4133 | 686.6667 | 80 | 69 | |
| 1 | 7 | 0.0949 | 0.4133 | 780.0000 | 81 | 69 | |
| 1 | 8 | 0.0985 | 0.4000 | 873.3333 | 82 | 70 | |
| 1 | 9 | 0.1022 | 0.4000 | 966.6667 | 83 | 70 | |
| 1 | 10 | 0.1058 | 0.4000 | 1060.0000 | 84 | 70 | |
| 1 | 11 | 0.1095 | 0.3733 | 1153.3333 | 85 | 72 | |
| 1 | 12 | 0.1131 | 0.3733 | 1246.6667 | 86 | 72 | |
| 1 | 13 | 0.1168 | 0.3733 | 1340.0000 | 87 | 72 | |
| 1 | 14 | 0.1204 | 0.3733 | 1433.3333 | 88 | 72 | |
| 1 | 15 | 0.1241 | 0.3733 | 1526.6667 | 89 | 72 | |
| 1 | 16 | 0.1277 | 0.3733 | 1620.0000 | 90 | 72 | |
| 1 | 17 | 0.1314 | 0.3733 | 1713.3333 | 91 | 72 | |
| 2 | 1 | 0.0000 | 0.3600 | -900.0000 | 55 | 73 | |
| 2 | 2 | 0.5219 | 0.3600 | 6100.0000 | 198 | 73 | |
| 2 | 3 | 0.5255 | 0.3600 | 6100.0000 | 199 | 73 | |
| 2 | 4 | 0.5292 | 0.3600 | 6100.0000 | 200 | 73 | |
| 2 | 5 | 0.5328 | 0.3600 | 6100.0000 | 201 | 73 | |
| 2 | 6 | 0.5365 | 0.3600 | 6100.0000 | 202 | 73 | |
| 2 | 7 | 0.5401 | 0.3600 | 6100.0000 | 203 | 73 | |
| 2 | 8 | 0.5438 | 0.3600 | 6100.0000 | 204 | 73 | |
| 2 | 9 | 0.5474 | 0.3600 | 6100.0000 | 205 | 73 | |
| 2 | 10 | 0.5511 | 0.3600 | 6100.0000 | 206 | 73 | |
| 2 | 11 | 0.5547 | 0.3600 | 6100.0000 | 207 | 73 | |
| 2 | 12 | 0.5584 | 0.3600 | 6100.0000 | 208 | 73 | |
| 2 | 13 | 0.5620 | 0.3600 | 6100.0000 | 209 | 73 | |
| 2 | 14 | 0.5657 | 0.3600 | 6100.0000 | 210 | 73 | |
| 2 | 15 | 0.5693 | 0.3600 | 6100.0000 | 211 | 73 | |
| 2 | 16 | 0.5730 | 0.3600 | 6100.0000 | 212 | 73 | |
| 2 | 17 | 0.5766 | 0.3600 | 6100.0000 | 213 | 73 | |
| 2 | 18 | 0.5803 | 0.3600 | 6100.0000 | 214 | 73 | |
| 2 | 19 | 0.5839 | 0.3600 | 6100.0000 | 215 | 73 | |
| 2 | 20 | 0.5876 | 0.3600 | 6100.0000 | 216 | 73 | |
| 2 | 21 | 0.5912 | 0.3600 | 6100.0000 | 217 | 73 | |
| 2 | 22 | 0.5949 | 0.3600 | 6100.0000 | 218 | 73 | |
| 2 | 23 | 0.5985 | 0.3600 | 6100.0000 | 219 | 73 | |
| 2 | 24 | 0.6022 | 0.3600 | 6100.0000 | 220 | 73 | |
| 2 | 25 | 0.6058 | 0.3600 | 6100.0000 | 221 | 73 | |
| 2 | 26 | 0.6095 | 0.3600 | 6100.0000 | 222 | 73 | |
| 2 | 27 | 0.6131 | 0.3600 | 6100.0000 | 223 | 73 | |
| 2 | 28 | 0.6168 | 0.3600 | 6100.0000 | 224 | 73 | |
| 2 | 29 | 0.6204 | 0.3600 | 6100.0000 | 225 | 73 | |
| 2 | 30 | 0.6241 | 0.3600 | 6100.0000 | 226 | 73 | |
| 2 | 31 | 0.6277 | 0.3600 | 6100.0000 | 227 | 73 | |
| 2 | 32 | 0.6314 | 0.3600 | 6100.0000 | 228 | 73 | |
| 2 | 33 | 0.6350 | 0.3600 | 6100.0000 | 229 | 73 | |
| 2 | 34 | 0.6387 | 0.3600 | 6100.0000 | 230 | 73 | |
| 2 | 35 | 0.6423 | 0.3600 | 6100.0000 | 231 | 73 | |
| 2 | 36 | 0.6460 | 0.3600 | 6100.0000 | 232 | 73 | |
| 2 | 37 | 0.6496 | 0.3600 | 6100.0000 | 233 | 73 | |
| 2 | 38 | 0.6533 | 0.3600 | 6100.0000 | 234 | 73 | |
| 2 | 39 | 0.6569 | 0.3600 | 6100.0000 | 235 | 73 | |
| 2 | 40 | 0.6606 | 0.3600 | 6100.0000 | 236 | 73 |
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | quality_warning | 待验证 | 2 | 2026-07-23T17:31:35+00:00 |